세계의 의료용 방사선 차폐 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 소재별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Medical Radiation Shielding Market Trends

The global medical radiation shielding market size was estimated at USD 1.47 billion in 2023 and is expected to grow at a CAGR of 6.69% from 2024 to 2030. This growth can be attributed to the rising incidence of chronic diseases and growing diagnostic imaging procedures. As the demand for radiotherapy and diagnostic imaging in treating cancer and other conditions grows, the need for effective radiation shielding solutions is also expected to increase to protect patients & healthcare workers from harmful radiation exposure. For instance, according to WHO, in 2022, there were around 20 million new cases of cancer and approximately 9.7 million deaths due to the disease. It is reported that about one in five people will develop cancer during their lifetime. Furthermore, technological advancements in imaging equipment and radiotherapy devices contribute to market expansion, as newer machines often require more sophisticated shielding materials. In addition, stringent government regulations and safety standards related to radiation protection propel the adoption of advanced shielding solutions.

Governments and healthcare regulatory agencies are implementing stricter guidelines and mandates for radiation safety in medical facilities. These regulations require adequate shielding measures to minimize radiation exposure during diagnostic and treatment procedures. For instance, the U.S. Nuclear Regulatory Commission (NRC) implemented regulations mandating the application of materials that shield against radiation during diagnostic imaging processes. This is to safeguard patients and healthcare workers from the adverse effects of radiation exposure. Technological advancements in medical radiation shielding materials and equipment are significantly driving the market. Innovative, nontoxic, and lead-free shielding alternatives have been developed that offer improved properties compared to traditional lead-based solutions.

For instance, an article published in Science Reports in December 2022 state that a new type of lightweight radiation protection has been developed through the use of electrospinning, which generates nanofibers from a blend of polymer and tungsten, creating a multilayered thin film similar in structure to the wings of a morpho butterfly. This innovative shield, fashioned into a flexible form similar to paper, measures just 0.1 mm thick. The market is also driven by expanding healthcare infrastructure, especially in developing regions. The growth of healthcare infrastructure in these regions creates a need for radiation-shielding solutions in newly established medical facilities. In addition, developing innovative shielding materials and equipment optimized for advanced treatment modalities, such as proton therapy & stereotactic radiosurgery, presents a promising opportunity for market growth.

Global Medical Radiation Shielding Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the medical radiation shielding market report based on product type, material, application, end-use, and region

• Product Type Outlook (Revenue, USD Million, 2018 - 2030)
• X-ray Shields

Lead Sheets and Plates

Lead Bricks

Lead Curtains

Lead Glass

Lead Aprons

• MRI Shields

RF Shielding Systems

Magnetic Shielding Systems

• Gamma Shields

Gamma Camera Shields

Positron Emission Tomography (PET) Shields

• Neutron Shields

Neutron Absorbers

Neutron Reflectors

• Material Outlook (Revenue, USD Million, 2018 - 2030)
• Lead-based Shielding
• Non-lead Shielding
• Hybrid Shielding
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Diagnostics

Radiography (X-ray)

Computed Tomography (CT)

Fluoroscopy

Mammography

Dental Imaging

• Therapeutics

Radiotherapy

Brachytherapy

Proton Therapy

• Nuclear Medicine

SPECT (Single Photon Emission Computed Tomography)

Positron Emission Tomography (PET)

• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Diagnostic Imaging Centers
• Other End-use
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

• Latin America

Brazil

Argentina

• Middle East and Africa (MEA)

South Africa

Saudi Arabia

Kuwait

UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Material
  • 1.2.3. Application
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Type outlook
  • 2.2.2. Material outlook
  • 2.2.3. Application Outlook
  • 2.2.4. End-use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Medical Radiation Shielding Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of Cancer
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Regulatory standards
    • 3.2.1.4. Growing healthcare expenditure
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Costs
    • 3.2.2.2. Material handling and disposal
    • 3.2.2.3. Need for customization
• 3.3. Medical Radiation Shielding Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. Medical Radiation Shielding Market: Treatment Estimates & Trend Analysis

• 4.1. Global Medical Radiation Shielding Market: Product Type Dashboard
• 4.2. Global Medical Radiation Shielding Market: Product Type Movement Analysis
• 4.3. Global Medical Radiation Shielding Market by Product Type, Revenue
• 4.4. X-ray Shields
  • 4.4.1. X-ray Shields market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Lead Sheets and Plates
    • 4.4.2.1. Lead Sheets and Plates market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Lead Bricks
    • 4.4.3.1. Lead Bricks market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Lead Curtains
    • 4.4.4.1. Lead Curtains market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Lead Glass
    • 4.4.5.1. Lead Glass market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Lead Aprons
    • 4.4.6.1. Lead Aprons market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. MRI Shields
  • 4.5.1. MRI Shields market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. RF Shielding Systems
    • 4.5.2.1. RF Shielding Systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Magnetic Shielding Systems
    • 4.5.3.1. Magnetic Shielding Systems market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Gamma Shields
  • 4.6.1. Gamma Shields market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Gamma Camera Shields
    • 4.6.2.1. Gamma Camera Shields market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Positron Emission Tomography (PET) Shields
    • 4.6.3.1. Positron Emission Tomography (PET) Shields market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Neutron Shields
  • 4.7.1. Neutron Shields market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.2. Neutron Absorbers
    • 4.7.2.1. Neutron Absorbers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.3. Neutron Reflectors
    • 4.7.3.1. Neutron Reflectors Shields market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Medical Radiation Shielding Market: Material Estimates & Trend Analysis

• 5.1. Global Medical Radiation Shielding Market: Material Dashboard
• 5.2. Global Medical Radiation Shielding Market: Material Movement Analysis
• 5.3. Global Medical Radiation Shielding Market Estimates and Forecasts, By Material, Revenue (USD Million)
• 5.4. Lead-based Shielding
  • 5.4.1. Lead-based Shielding market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Non-lead Shielding
  • 5.5.1. Non-lead Shielding market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Hybrid Shielding
  • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Medical Radiation Shielding Market: Application Estimates & Trend Analysis

• 6.1. Global Medical Radiation Shielding Market: Application Dashboard
• 6.2. Global Medical Radiation Shielding Market: Application Movement Analysis
• 6.3. Global Medical Radiation Shielding Market Estimates and Forecasts, by Application, Revenue (USD Million)
• 6.4. Diagnostics
  • 6.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Radiography (X-ray)
    • 6.4.2.1. Radiography (X-ray) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Computed Tomography (CT)
    • 6.4.3.1. Computed Tomography (CT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Fluoroscopy
    • 6.4.4.1. Fluoroscopy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Mammography
    • 6.4.5.1. Mammography market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Dental Imaging
    • 6.4.6.1. Dental Imaging market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Therapeutics
  • 6.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Radiotherapy
    • 6.5.2.1. Radiotherapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Brachytherapy
    • 6.5.3.1. Brachytherapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Proton Therapy
    • 6.5.4.1. Proton Therapy market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Nuclear Medicine
  • 6.6.1. Nuclear Medicine market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. SPECT (Single Photon Emission Computed Tomography)
    • 6.6.2.1. SPECT (Single Photon Emission Computed Tomography) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Positron Emission Tomography (PET)
    • 6.6.3.1. Positron Emission Tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Medical Radiation Shielding Market: End Use Estimates & Trend Analysis

• 7.1. Global Medical Radiation Shielding Market: End-use Dashboard
• 7.2. Global Medical Radiation Shielding Market: End-use Movement Analysis
• 7.3. Global Medical Radiation Shielding Market Estimates and Forecasts by End-use, Revenue (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic Imaging Centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Other End-use
  • 7.6.1. Other End-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Medical Radiation Shielding Market: Regional Estimates & Trend Analysis by Product Type, Material, Application and End-use

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key customers
  • 9.2.3. Key company market share analysis, 2023
  • 9.2.4. Amray Group
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. ETS-Lindgren
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Gaven Industries
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. MarShield
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. MAVIG GmbH
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. NELCO
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Nuclear Shields B.V.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Radiation Protection products, Inc.
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12 VacuTec MeBtechnik GmbH
    • 9.2.12.1 Company overview
    • 9.2.12.2 Financial performance
    • 9.2.12.3 Product benchmarking
    • 9.2.12.4 Strategic initiatives
  • 9.2.13 Veritas Medical Solutions
    • 9.2.13.1 Company overview
    • 9.2.13.2 Financial performance
    • 9.2.13.3 Product benchmarking
    • 9.2.13.4 Strategic initiatives